Christopher Downs

Insider Reports History

Location
Madison Heights, MI
Signature
/s/ Christopher Downs
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Downs:

Company Role Class Num Shares Value Price $ Report Date Ownership
EBET, Inc. Director Restricted Stock Units 75,000 $7,500 $0.1000 09 Feb 2023 Direct
EBET, Inc. Director Common Stock 6,300 $630 $0.1000 09 Feb 2023 Direct
CNS Pharmaceuticals, Inc. Chief Financial Officer Option to purchase common stock 4,881 17 Nov 2025 Direct

Insider Reports Filed by Christopher Downs

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CNSP CNS Pharmaceuticals, Inc. 17 Nov 2025 1 $0 4 Chief Financial Officer 19 Nov 2025, 17:00
CNSP CNS Pharmaceuticals, Inc. 08 Apr 2024 2 $0 4 Chief Financial Officer 10 Apr 2024, 21:51
CNSP CNS Pharmaceuticals, Inc. 01 Feb 2024 3 +$20,000 4 Chief Financial Officer 06 Feb 2024, 10:27
CNSP CNS Pharmaceuticals, Inc. 22 Aug 2023 1 +$34,177 4 Chief Financial Officer 23 Aug 2023, 09:00
CNSP CNS Pharmaceuticals, Inc. 28 Apr 2023 2 $0 4 Chief Financial Officer 01 May 2023, 18:59
CNSP CNS Pharmaceuticals, Inc. 17 Apr 2023 1 +$9,920 4 Chief Financial Officer 18 Apr 2023, 08:00
CNSP CNS Pharmaceuticals, Inc. 29 Mar 2023 1 $0 4 Chief Financial Officer 31 Mar 2023, 19:28
/report/000168316823000760-downs-christopher-2023-02-09 EBET, Inc. 09 Feb 2023 2 $0 4 Director 10 Feb 2023, 16:34
CNSP CNS Pharmaceuticals, Inc. 28 Apr 2022 1 $0 4 Chief Financial Officer 29 Apr 2022, 17:12
CNSP CNS Pharmaceuticals, Inc. 11 Mar 2022 1 +$10,230 4 Chief Financial Officer 14 Mar 2022, 09:40
/report/000168316822000872-downs-christopher-2022-02-09 Esports Technologies, Inc. 09 Feb 2022 1 $0 4 Director 11 Feb 2022, 15:36
CNSP CNS Pharmaceuticals, Inc. 06 Dec 2021 1 +$4,702 4 Chief Financial Officer 07 Dec 2021, 07:30
CNSP CNS Pharmaceuticals, Inc. 19 Nov 2021 1 +$5,192 4 Chief Financial Officer 22 Nov 2021, 07:47